Trials / Completed
CompletedNCT01565343
A Study of 18F-AV-45 in Alzheimer's Disease (AD) and Healthy Volunteers
Test-retest Reproducibility of 18F-AV-45 for Brain Imaging of Amyloid in Healthy Volunteers and Alzheimer's Disease Patients
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Avid Radiopharmaceuticals · Industry
- Sex
- All
- Age
- 35 Years
- Healthy volunteers
- Accepted
Summary
This study will test if two AV-45 PET scans up to 4 weeks apart in AD subjects and healthy volunteers provide the same results. The study will also test two different AV-45 injection methods in a small subgroup of enrolled AD subjects (slow vs. fast bolus group).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | florbetapir F 18 | IV injection, 370MBq (10mCi) |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2009-04-01
- Completion
- 2009-04-01
- First posted
- 2012-03-28
- Last updated
- 2012-05-10
- Results posted
- 2012-05-02
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01565343. Inclusion in this directory is not an endorsement.